Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Strong Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Aravive, Inc. Common Stock (ARAV)

Pharmaceutical Preparations

https://www.aravive.com

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

RIVER OAKS TOWER, 3730 KIRBY DRIVE, SUITE 1200
HOUSTON, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/21/2014

Market Cap

2,949,860

Shares Outstanding

73,560,000

Weighted SO

73,562,648

Total Employees

N/A

Upcoming Earnings

03/20/2024

Similar Tickers

MGTA --.--%

ASLN --.--%

AVRO --.--%

AGLE --.--%

AUTL --.--%

Beta

2.1860

Last Div

0.0000

Range

0.04-2.46

Chg

-0.0062

Avg Vol

2242572

Mkt Cap

2949860

Exch

NASDAQ

Country

US

Phone

936 355 1910

DCF Diff

-0.5836

DCF

0.7008

Div Yield

0.0000

P/S

0.4217

EV Multiple

0.0375

P/FV

1.7938

Div Yield %

0.0000

P/E

-0.0376

PEG

0.0022

Payout

0.0000

Current Ratio

0.9780

Quick Ratio

0.8730

Cash Ratio

0.8730

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

37.0757

CCC

-37.0757

Gross Margin

-6.6323

Op Margin

-3.7268

Pretax Margin

-5.6965

Net Margin

-11.6011

Eff Tax Rate

0.4538

ROA

-6.2189

ROE

7.0458

ROCE

-7.9673

NI/EBT

2.0365

EBT/EBIT

1.5285

EBIT/Rev

-3.7268

Debt Ratio

0.1860

D/E

1.4268

LT Debt/Cap

0.1525

Total Debt/Cap

0.5879

Int Coverage

-0.7903

CF/Debt

-24.4961

Equity Multi

7.6714

Rec Turnover

0.0000

Pay Turnover

9.8447

Inv Turnover

0.0000

FA Turnover

6.5130

Asset Turnover

0.5361

OCF/Share

-0.7813

FCF/Share

-0.7815

Cash/Share

0.1122

OCF/Sales

-8.4992

FCF/OCF

1.0002

CF Coverage

-24.4961

ST Coverage

-28.0302

CapEx Coverage

-5404.7273

Div&CapEx Cov

-5404.7273

P/BV

1.7938

P/B

1.7938

P/S

0.4217

P/E

-0.0376

P/FCF

-0.0496

P/OCF

-0.0513

P/CF

-0.0513

PEG

0.0022

P/S

0.4217

EV Multiple

0.0375

P/FV

1.7938

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation